Indian Biotech Firms Pandorum and Nucelion Partner to Develop Advanced Regenerative Therapies for Eye Diseases
Nucelion Therapeutics, a wholly owned subsidiary of Bharat Biotech, will provide specialised process development and manufacturing support for Pandorum’s proprietary designer-exosome technology. The collaboration aims to develop reproducible manufacturing processes capable of supporting future clinical studies in India and international markets, subject to regulatory approvals.